Clinical trial
Pain Reduction Caused by the Combined Treatment of Neural Mobilization, Oral Gabapentin and Oral Ibuprofen Arginine in the Treatment of Carpal Tunnel Syndrome
NCT06781489 is registered in ClinicalTrials.gov with Universidad Europea de Madrid as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pain Reduction Caused by the Combined Treatment of Neural Mobilization, Oral Gabapentin and Oral Ibuprofen Arginine in the Treatment of Carpal Tunnel Syndrome
- Lead sponsor
- Universidad Europea de Madrid
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 19, 2025
- Completion date
- March 29, 2025
- Enrollment
- 129 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.